Cargando…

Impact of HIV-1 Diversity on Its Sensitivity to Neutralization

The HIV-1 pandemic remains a major burden on global public health and a vaccine to prevent HIV-1 infection is highly desirable but has not yet been developed. Among the many roadblocks to achieve this goal, the high antigenic diversity of the HIV-1 envelope protein (Env) is one of the most important...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stefic, Karl, Bouvin-Pley, Mélanie, Braibant, Martine, Barin, Francis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789624/ https://www.ncbi.nlm.nih.gov/pubmed/31349655 http://dx.doi.org/10.3390/vaccines7030074

Ejemplares similares

Probing the compartmentalization of HIV-1 in the central nervous system through its neutralization properties
por: Stefic, Karl, et al.
Publicado: (2017)

A26 Probing the compartmentalization of HIV-1 in the central nervous system through its neutralization properties
por: Stefic, K, et al.
Publicado: (2018)

Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic
por: Bouvin-Pley, Mélanie, et al.
Publicado: (2013)

Common evolutionary features of the envelope glycoprotein of HIV-1 in patients belonging to a transmission chain
por: Beretta, Maxime, et al.
Publicado: (2020)

The role of neutralizing antibodies in prevention of HIV-1 infection: what can we learn from the mother-to-child transmission context?
por: Braibant, Martine, et al.
Publicado: (2013)

V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1
por: Morgand, Marion, et al.
Publicado: (2016)

Human Immunodeficiency Virus Type-1 (HIV-1) Continues to Evolve in Presence of Broadly Neutralizing Antibodies More than Ten Years after Infection
por: Chaillon, Antoine, et al.
Publicado: (2012)

Cross-group neutralization of HIV-1 and evidence for conservation of the PG9/PG16 epitopes within divergent groups of HIV-1
por: Braibant, M, et al.
Publicado: (2012)

Epitope convergence of broadly HIV-1 neutralizing IgA and IgG antibody lineages in a viremic controller
por: Lorin, Valérie, et al.
Publicado: (2022)

Difficulties of Identifying the Early HIV Antibody Seroconversion Period Depending on the Confirmatory Assay
por: Stefic, Karl, et al.
Publicado: (2020)

The breadth of maternal HIV-1 specific neutralizing antibodies is not associated with a lower risk of mother-to-infant transmission
por: Chaillon, A, et al.
Publicado: (2012)

Continuous evolution of HIV-1 more than ten years after infection in an elite neutralizer
por: Chaillon, A, et al.
Publicado: (2012)

P04-17. The N-glycosylation sites N295, N332 and N392 of gp120 are necessary but not sufficient for HIV-1 to be neutralized by 2G12
por: Chaillon, A, et al.
Publicado: (2009)

Geospatial HIV-1 subtype C gp120 sequence diversity and its predicted impact on broadly neutralizing antibody sensitivity
por: Sutar, Jyoti, et al.
Publicado: (2021)

Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells
por: Dufloo, Jérémy, et al.
Publicado: (2022)

In Vivo Emergence of HIV-1 Highly Sensitive to Neutralizing Antibodies
por: Aasa-Chapman, Marlén M. I., et al.
Publicado: (2011)

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
por: Landais, Elise, et al.
Publicado: (2018)

An Overview of Human Anti-HIV-1 Neutralizing Antibodies against Diverse Epitopes of HIV-1
por: Kumar, Sanjeev, et al.
Publicado: (2023)

Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth
por: Chukwuma, Valentine U., et al.
Publicado: (2018)

Nanobodies that Neutralize HIV
por: Weiss, Robin A., et al.
Publicado: (2019)

Neutralizing antibodies to HIV-1 induced by immunization
por: McCoy, Laura E., et al.
Publicado: (2013)

Virus Evolution and Neutralization Sensitivity in an HIV-1 Subtype B′ Infected Plasma Donor with Broadly Neutralizing Activity
por: Hu, Yuanyuan, et al.
Publicado: (2021)

Impact of HIV-1 Backbone on Neutralization Sensitivity: Neutralization Profiles of Heterologous Envelope Glycoproteins Expressed in Native Subtype C and CRF01_AE Backbone
por: Chenine, Agnès-Laurence, et al.
Publicado: (2013)

Nanoparticle Vaccines for Inducing HIV-1 Neutralizing Antibodies
por: Brinkkemper, Mitch, et al.
Publicado: (2019)

Harnessing the protective potential of HIV-1 neutralizing antibodies
por: Smith, S Abigail, et al.
Publicado: (2016)

Neutralizing Antibodies Targeting HIV-1 gp41
por: Caillat, Christophe, et al.
Publicado: (2020)

The Impact of Genetic Surfing on Neutral Genomic Diversity
por: Schlichta, Flávia, et al.
Publicado: (2022)

Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory Antibodies
por: Zhang, Zhiqing, et al.
Publicado: (2016)

HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
por: Dufloo, Jérémy, et al.
Publicado: (2018)

Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities
por: Liu, Yubin, et al.
Publicado: (2020)

Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence features
por: Magaret, Craig A., et al.
Publicado: (2019)

Clinical performance of four immunoassays for antibodies to SARS-CoV-2, including a prospective analysis for the diagnosis of COVID-19 in a real-life routine care setting
por: Marlet, Julien, et al.
Publicado: (2020)

Neutralization tiers of HIV-1
por: Montefiori, David C., et al.
Publicado: (2018)

Correction to: The Impact of Genetic Surfing on Neutral Genomic Diversity
Publicado: (2023)

The impact of differences in viral entry and trafficking on the mechanism of HIV-1 neutralization
por: Cincotta, CD Macedo, et al.
Publicado: (2012)

Strategies for inducing effective neutralizing antibody responses against HIV-1
por: del Moral-Sánchez, Iván, et al.
Publicado: (2019)

Broadly neutralizing antibodies and vaccine design against HIV-1 infection
por: Wang, Qian, et al.
Publicado: (2019)

Immune System Regulation in the Induction of Broadly Neutralizing HIV-1 Antibodies
por: Kelsoe, Garnett, et al.
Publicado: (2013)

Neutralizing Antibody-Based Prevention of Cell-Associated HIV-1 Infection
por: Parsons, Matthew S, et al.
Publicado: (2018)

Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
por: Torrents de la Peña, Alba, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u5rosika84dmfdq905tic1ic09